The diabetes group were significantly more likely to be prescribed a statin on discharge (67%, compared to 50% pre-diabetes and 39% no diabetes, p < 0.001) and were also more likely to be prescribed a beta blocker compared to both the pre-diabetes and no diabetes groups (72%, compared to 69% pre-diabetes, 64% no diabetes, p = 0.07), although this did not reach statistical significance (Table S3 ).
← all excerpts
Routine use of HbA1c amongst inpatients hospitalised with decompensated heart failure and the association of dysglycaemia with outcomes.
2
—
—
The sentences
There was a trend toward the presence of pre-diabetes being associated with a lower risk of 6-month mortality compared to no diabetes, when adjusted for age, eGFR and Charlson comorbidity score (excluding diabetes and age), with an OR of 0.34 (0.11–1.12, p = 0.08) but this failed to reach significance.